Sanos Group
Jeppe Ragnar Andersen is the Group CEO at Sanos Group A/S, the parent company of NBCD, Sanos Clinic A/S, Studies&Me, Blueskin, and Omicron. As the CEO of NBCD A/S, a niche clinical CRO specialized in osteoarthritis, Jeppe has shown great leadership since 2014. Jeppe is also a Board Member at Ousia Pharma and was previously the Chairman of The Board at Webnuts A/S. With a background in pharmacy and various business and leadership certificates from top universities, Jeppe has a strong foundation for their roles in the pharmaceutical and clinical research industry.
Sanos Group
Sanos Group is a Full Circle Clinical Research & Development Organization encompassing five independent business units: NBCD, Sanos Clinic, Sanos Supply, Studies&Me and Blueskin. Every division within the Sanos Group is committed to delivering top-tier clinical research, constantly enhancing our approach to pioneering innovative clinical trials for both clients and patients.